1. EDM Strategy for Working with Countries: the Uganda Example
Mr Martin Oteba
Chief Pharmacist
MOH UGANDA
29 September 2004

2. Expected Outcomes and Activities 2003
Policy and Management:
Report of the assessment of the Pharmaceutical Situation
Organize consultative workshop to review draft report; Finalize draft report; and Print and disseminate final report
Stakeholders sensitised on public health issues on TRIPS/IPR
Organise preparatory meeting for workshop; and Organize workshop for stakeholders
Access:
Improved drug management at district level
Identify relevant courses for training in drug management; and Organise attendance to courses for district health personnel
Availability of key essential medicines monitored
Develop assessment tool; Collect data and Produce monthly reports

3. Expected Outcomes and Activities 2003
Quality Assurance:
Quality monitoring of the quality of TB medicines at national level
Collect & transmit samples for lab. analysis; and Receipt and provision of analysis results to national authorities
Quality of drugs at national level monitored
Collect drug samples and send for analysis
Rational Use of Medicine:
Guidelines for the rational use of ARVs developed
Drafting and field test guidelines; Consultative workshop to adopt final guidelines; and Adopted guidelines printed
Support provided for creation of a Drug Information Centre (DIC)
Identify and procure reference materials; and Deliver reference materials to DIC
Guidelines for establishment of Hospital DTCs developed
Prepare TOR for committee; Create committee; and Draft guidelines

4. Activity Implementation and Achievement of Expected outcomes
Policy and Management:
Report of the assessment of the Pharmaceutical Situation
Consultative workshop held in July 2003; Draft report ready in Nov 2003;
and Final report printed and disseminated in Dec 2003
Stakeholders sensitised on public health issues on TRIPS/IPR
Preparatory arrangements completed in Aug 2003; and Workshop &
Report completed in Dec 2003
Access:
Improved drug management at district level
3 courses and content identified in June 2003; 152 health personnel
trained by Nov 2003; and Training report ready in Nov 2003
Availability of key essential medicines monitored
Monthly reports of availability of key essential medicines from
MOH HMIS data made for the period Jan – July 2003

5. Activity Implementation and Achievement of Expected outcomes
Quality Assurance:
Monitoring of the quality of TB medicines at national level
No funding; Activity re-scheduled to 2004
Quality of drugs at national level monitored
Rational Use of Medicine:
Guidelines for the rational use of ARVs developed
Draft guidelines field tested in May 2003; Consultative workshop held in Aug 2003; and Printed Guidelines available in Dec 2003
Support provided for creation of a Drug Information Centre
List of reference materials ready in May 2003; Procurement delayed; and Activity re-scheduled to March 2004
Guidelines for the establishment of Hospital DTCs developed
TORs developed & Committee set up proposed in Jun 2003;
Drafting of guidelines re-scheduled to 2004

6. TRADITIONAL MEDICINE
Support to the development of the TRM National Plan of Action:
Support TRM Working Group to develop National TRM Plan of Action
No Funding; Activity re-scheduled to 2004
TRM Day celebrated: Delivered
Support to the TRM Working Group to organize and commemorate the Inaugural Africa TRM Day
TRM Day celebrated on 01 November 2003

7. Utilization of Funds 12 000 (32%) 10 000 10 000 (100%) 10 000 (100%)
COMPONENT
PLANNED BUDGET
ALLOCATED
UTILISED
BALANCE
POLICY
10 000
(100%)
(100%)
ACCESS
6 000
(100%)
(100%)
QUALITY ASSURANCE
RATIONAL USE
19 000
(100%)
(37%)
(63%)
TRADITIONAL MEDICINE
(30%)
(100%)
TOTAL
51 000
(75%)
(68%)
(32%)

8. CONSTRAINTS / LESSONS LEARNT
Lack of an appropriate structure & human resources in MOH to coordinate the pharmaceutical sector
Inadequate funding
Lessons Learnt:
Need to increase funding for essential medicines
Availability of medicines and their rational use is improved by strengthening human resources capacity for drug management

9. CONCLUSION / RECOMMENDATIONS
Focus support on procurement management and pricing, quality, safety and rational use of medicines including traditional medicines
Support national efforts to scale up access to essential medicines for priority diseases (HIV/AIDS, TB and Malaria) and for the establishment of a reliable drug management information system

10. PROPOSED EXPECTED OUTCOMES MAY-DECEMBER 2004
Policy:
National mechanism for M & E the NDP 2002 established
National capacity for NDP implementation strengthened
Access:
Pricing for essential medicines surveyed
Strengthened capacity for district drug procurement and management
Quality Assurance
National Quality Control Lab. staff capacity in GLP strengthened
Quality of medicines at national level monitored
Rational Use
Guidelines for establishment of Hospital DTCs developed
Priority requirements for establishment of the National DIC procured
Traditional Medicine
National TRM Plan of Action developed
Guidelines for registration of local TRM finalized and disseminated